MAPT and Alzheimer disease: Animal models of T2DM with hyperglycaemia exhibit AD‐type pathological changes in the brain including tau hyperphosphorylation, tau aggregates and neuroinflammation (Engin & Engin, 2021; Murtishaw et al., 2018).